NASDAQ
Innovent Biologics, Inc. (IVBXF) has a market cap of $9.40B as of Friday, May 22, 2026. The IVBXF market cap is up 0.49% over the past 30 days and has declined 20.35% over the past year. Market capitalization represents the total market value of a company's outstanding shares, calculated by multiplying the stock price by the total number of shares outstanding.
No price data available for this timeframe.